Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 401

1.

Surgeon and hospital volume outcomes in bariatric surgery: a population-level study.

Bouchard P, Demyttenaere S, Court O, Franco EL, Andalib A.

Surg Obes Relat Dis. 2020 Jan 23. pii: S1550-7289(20)30028-9. doi: 10.1016/j.soard.2020.01.012. [Epub ahead of print]

PMID:
32088111
2.

Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.

El-Zein M, Cheishvili D, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Szyf M, Franco EL; MARKER study group.

Int J Cancer. 2020 Jan 25. doi: 10.1002/ijc.32880. [Epub ahead of print]

PMID:
31983058
3.

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.

Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J; FRIDA Study Group.

JAMA Netw Open. 2019 Nov 1;2(11):e1915781. doi: 10.1001/jamanetworkopen.2019.15781.

4.

Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.

Malagón T, Louvanto K, Ramanakumar AV, Koushik A, Coutlée F, Franco EL; Biomarkers of Cervical Cancer Risk Study Team.

Gynecol Oncol. 2019 Nov;155(2):245-253. doi: 10.1016/j.ygyno.2019.09.010. Epub 2019 Oct 8.

PMID:
31604665
5.

Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction.

Widdice LE, Bernstein DI, Franco EL, Ding L, Brown DR, Ermel AC, Higgins L, Kahn JA.

Vaccine. 2019 Oct 23;37(45):6832-6841. doi: 10.1016/j.vaccine.2019.08.052. Epub 2019 Sep 30.

PMID:
31582269
6.

Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.

Sorin M, Franco EL, Quesnel-Vallée A.

Curr Oncol. 2019 Aug;26(4):266-269. doi: 10.3747/co.26.4867. Epub 2019 Aug 1. No abstract available.

7.

Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Wissing MD, Burchell AN, El-Zein M, Tellier PP, Coutlée F, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1825-1834. doi: 10.1158/1055-9965.EPI-19-0618. Epub 2019 Sep 5.

PMID:
31488413
8.

The role of healthcare providers in HPV vaccination programs - A meeting report.

Vorsters A, Bonanni P, Maltezou HC, Yarwood J, Brewer NT, Bosch FX, Hanley S, Cameron R, Franco EL, Arbyn M, Muñoz N, Kojouharova M, Pattyn J, Baay M, Karafillakis E, Van Damme P.

Papillomavirus Res. 2019 Dec;8:100183. doi: 10.1016/j.pvr.2019.100183. Epub 2019 Aug 30.

9.

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.

El-Zein M, Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, Colares de Borba P, Teixeira JC, Moscicki AB, Harper DM, Tyring SK, Ramjattan B, Dubin G, Franco EL; HPV-007 Study Group.

Sex Transm Dis. 2019 Oct;46(10):663-669. doi: 10.1097/OLQ.0000000000001053.

10.

Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.

Coldman AJ, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan DJ, Lee M, Elwood-Martin R, Gentile L, Peacock S, Stuart GCE, Franco EL, Ogilvie GS.

Int J Cancer. 2020 Apr 1;146(7):1810-1818. doi: 10.1002/ijc.32524. Epub 2019 Jul 4.

PMID:
31245842
11.

Corrigendum to "Estimates of the future burden of cancer attributable to infections in Canada" [Prev. Med. 122 (2019) 118-127].

Volesky KD, El-Zein M, Franco EL, Brenner DR, Friedenreich CM, Ruan Y; ComPARe Study Team.

Prev Med. 2019 Dec;129:105731. doi: 10.1016/j.ypmed.2019.05.019. Epub 2019 May 29. No abstract available.

PMID:
31151673
12.

Corrigendum to "Cancers attributable to infections in Canada" [Prev. Med. 122 (2019) 109-117].

Volesky KD, El-Zein M, Franco EL, Brenner DR, Friedenreich CM, Ruan Y; ComPARe Study Team.

Prev Med. 2019 Dec;129:105730. doi: 10.1016/j.ypmed.2019.05.018. Epub 2019 May 29. No abstract available.

PMID:
31151672
13.

The burden of cancer attributable to modifiable risk factors in Canada: Methods overview.

Brenner DR, Friedenreich CM, Ruan Y, Poirier AE, Walter SD, King WD, Franco EL, Demers PA, Villeneuve PJ, Grevers X, Nuttall R, Smith LM, Volesky KD, O'Sullivan DE, De P; ComPARe Study Team.

Prev Med. 2019 May;122:3-8. doi: 10.1016/j.ypmed.2019.03.007.

PMID:
31078170
14.

Estimates of the future burden of cancer attributable to infections in Canada.

Volesky KD, El-Zein M, Franco EL, Brenner DR, Friedenreich CM, Ruan Y; ComPARe Study Team.

Prev Med. 2019 May;122:118-127. doi: 10.1016/j.ypmed.2019.04.006. Erratum in: Prev Med. 2019 Dec;129:105731.

PMID:
31078165
15.

Cancers attributable to infections in Canada.

Volesky KD, El-Zein M, Franco EL, Brenner DR, Friedenreich CM, Ruan Y; ComPARe Study Team.

Prev Med. 2019 May;122:109-117. doi: 10.1016/j.ypmed.2019.03.035. Erratum in: Prev Med. 2019 Dec;129:105730.

PMID:
31078164
16.

Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples.

Wissing MD, Louvanto K, Comète E, Burchell AN, El-Zein M, Rodrigues A, Tellier PP, Coutlée F, Franco EL.

J Infect Dis. 2019 Aug 30;220(7):1152-1161. doi: 10.1093/infdis/jiz238.

PMID:
31063542
17.

Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, Behr MA, Franco EL; CASSIS Study Group*.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1134-1140. doi: 10.1158/1055-9965.EPI-18-1338. Epub 2019 Apr 23.

PMID:
31015201
18.

Genetic variants in CYP and GST genes, smoking and risk for head and neck cancers: a gene-environment interaction hospital-based case-control study among Canadian Caucasians.

ThekkePurakkal AS, Nicolau B, Burk RD, Franco EL, Schlecht NF.

Carcinogenesis. 2019 Apr 2. pii: bgz051. doi: 10.1093/carcin/bgz051. [Epub ahead of print]

PMID:
30938417
19.

Restoring Dignity in Academic Publishing Is a Collective Duty.

Shapiro SB, Franco EL.

JDR Clin Trans Res. 2019 Jan;4(1):5-8. doi: 10.1177/2380084418806839. Epub 2018 Oct 8. No abstract available.

PMID:
30931756
20.

Lack of Association between Human Papillomavirus Types 6 and 11 Genetic Variants and Cervical Abnormalities: The Ludwig-McGill Cohort Study.

Sichero L, El-Zein M, Ferreira S, Franco EL, Villa LL; Ludwig-McGill Cohort Study.

Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1086-1088. doi: 10.1158/1055-9965.EPI-19-0114. Epub 2019 Mar 13.

PMID:
30867221
21.

Improving the reporting of cancer-specific mortality and survival in research using cancer registry data.

Wissing MD, Greenwald ZR, Franco EL.

Cancer Epidemiol. 2019 Apr;59:232-235. doi: 10.1016/j.canep.2019.02.004. Epub 2019 Mar 2.

PMID:
30836221
22.

The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042.

Poirier AE, Ruan Y, Walter SD, Franco EL, Villeneuve PJ, King WD, Volesky KD, O'Sullivan DE, Friedenreich CM, Brenner DR; ComPARe Study Team.

Cancer Epidemiol. 2019 Apr;59:199-207. doi: 10.1016/j.canep.2019.02.011. Epub 2019 Mar 1.

23.

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada.

Gauthier B, Cerigo H, Coutlée F, Franco EL, Brassard P.

Int J Circumpolar Health. 2018 Dec;77(1):1556556. doi: 10.1080/22423982.2018.1556556.

24.

Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Malagón T, Louvanto K, Wissing M, Burchell AN, Tellier PP, El-Zein M, Coutlée F, Franco EL.

Lancet Infect Dis. 2019 Mar;19(3):317-326. doi: 10.1016/S1473-3099(18)30655-8. Epub 2019 Feb 10.

PMID:
30745276
25.

Limitations of simulation models for cervical cancer screening - Authors' reply.

Malagón T, Kulasingam S, Franco EL.

Lancet Oncol. 2019 Feb;20(2):e69. doi: 10.1016/S1470-2045(19)30012-9. No abstract available.

PMID:
30712802
26.

Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.

Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Saavedra-Lara N, Kuri-Morales P, Pesqueira-Villegas E, Luna-Gordillo R, Franco EL, Lazcano-Ponce E.

Salud Publica Mex. 2018 Nov-Dic;60(6):722-733. doi: 10.21149/9891.

PMID:
30699277
27.

Prevention of cervical cancer in Latin America: Future challenges and opportunities.

Franco EL.

Salud Publica Mex. 2018 Nov-Dic;60(6):609-611. doi: 10.21149/10071. No abstract available.

PMID:
30699263
28.

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA.

Pediatrics. 2019 Feb;143(2). pii: e20181902. doi: 10.1542/peds.2018-1902. Epub 2019 Jan 22.

29.

Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals.

El-Zein M, Coutlée F, Tellier PP, Roger M, Franco EL, Burchell AN; HITCH Study Group.

JMIR Res Protoc. 2019 Jan 16;8(1):e11284. doi: 10.2196/11284.

30.

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA.

Hum Vaccin Immunother. 2019;15(7-8):1962-1969. doi: 10.1080/21645515.2018.1564438. Epub 2019 Feb 20.

31.

Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Head Neck. 2019 Mar;41(3):678-685. doi: 10.1002/hed.25436. Epub 2019 Jan 3.

PMID:
30605251
32.

Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.

Isidean SD, Wang Y, Mayrand MH, Ratnam S, Coutlée F, Franco EL, Abrahamowicz M; CCCaST Study Group.

Int J Cancer. 2019 May 15;144(10):2408-2418. doi: 10.1002/ijc.31970. Epub 2019 Jan 21.

PMID:
30411802
33.

Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.

Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL.

Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470-2045(18)30536-9. Epub 2018 Nov 1. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30392810
34.

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.

Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, Ceballos KM, Jang D, Chernesky M, Franco EL, Ogilvie GS, Coldman AJ, Krajden M.

J Clin Virol. 2018 Nov;108:32-37. doi: 10.1016/j.jcv.2018.09.004. Epub 2018 Sep 10.

PMID:
30223252
35.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

36.

Estimating the current and future cancer burden in Canada: methodological framework of the Canadian population attributable risk of cancer (ComPARe) study.

Brenner DR, Poirier AE, Walter SD, King WD, Franco EL, Demers PA, Villeneuve PJ, Ruan Y, Khandwala F, Grevers X, Nuttall R, Smith L, De P, Volesky K, O'Sullivan D, Hystad P, Friedenreich CM; ComPARe Study Group.

BMJ Open. 2018 Aug 1;8(7):e022378. doi: 10.1136/bmjopen-2018-022378.

37.

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA.

J Adolesc Health. 2018 Jul;63(1):43-49. doi: 10.1016/j.jadohealth.2018.01.005.

38.

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ.

JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464. Erratum in: JAMA. 2018 Dec 4;320(21):2273.

39.

Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review.

Malagón T, Laurie C, Franco EL.

Expert Rev Vaccines. 2018 May;17(5):395-409. doi: 10.1080/14760584.2018.1471986. Epub 2018 May 21. Review.

PMID:
29715059
40.

Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.

Magnan S, Tota JE, El-Zein M, Burchell AN, Schiller JT, Ferenczy A, Tellier PP, Coutlée F, Franco EL; CATCH Study Group.

Clin Microbiol Infect. 2019 Feb;25(2):210-216. doi: 10.1016/j.cmi.2018.04.012. Epub 2018 Apr 21.

41.

Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb W, Hemmings R, Behr MA, Franco EL; CASSIS Study Group.

Gynecol Oncol. 2018 Jun;149(3):491-497. doi: 10.1016/j.ygyno.2018.04.004. Epub 2018 Apr 17.

PMID:
29678360
42.

Journal editors as curators of scholarship: A case study in repairing the scientific record.

Franco EL, Shinder GA, Tota JE, Volesky K, Isidean SD.

Prev Med. 2018 May;110:114-115. doi: 10.1016/j.ypmed.2018.02.027. No abstract available.

PMID:
29524988
43.

Self-sampling for cervical cancer screening: Empowering women to lead a paradigm change in cancer control.

Franco EL.

Curr Oncol. 2018 Feb;25(1):e1-e3. doi: 10.3747/co.25.3969. Epub 2018 Feb 28. No abstract available.

44.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

45.

Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.

Saccucci M, Franco EL, Ding L, Bernstein DI, Brown D, Kahn JA.

Sex Transm Dis. 2018 Apr;45(4):260-265. doi: 10.1097/OLQ.0000000000000731.

PMID:
29465705
46.

The performance of mobile screening units in a breast cancer screening program in Brazil.

Greenwald ZR, Fregnani JH, Longatto-Filho A, Watanabe A, Mattos JSC, Vazquez FL, Franco EL.

Cancer Causes Control. 2018 Feb;29(2):233-241. doi: 10.1007/s10552-017-0995-7. Epub 2017 Dec 18.

PMID:
29250701
47.

Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.

Farsi NJ, Rousseau MC, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Souliéres D, Coutlée F, Hier M, Madathil S, Franco EL, Nicolau B.

Carcinogenesis. 2017 Dec 7;38(12):1188-1195. doi: 10.1093/carcin/bgx106.

PMID:
29029021
48.

Mobile Screening Units for the Early Detection of Cancer: A Systematic Review.

Greenwald ZR, El-Zein M, Bouten S, Ensha H, Vazquez FL, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1679-1694. doi: 10.1158/1055-9965.EPI-17-0454. Epub 2017 Oct 4. Review.

49.

Estimating HPV DNA Deposition Between Sexual Partners Using HPV Concordance, Y Chromosome DNA Detection, and Self-reported Sexual Behaviors.

Malagón T, Burchell AN, El-Zein M, Guénoun J, Tellier PP, Coutlée F, Franco EL; HITCH Study Group.

J Infect Dis. 2017 Dec 5;216(10):1210-1218. doi: 10.1093/infdis/jix477.

50.

Who's Not Protected in the Herd? Factors Associated with Vaccine-Type HPV in Unvaccinated Women.

Smith C, Ding L, Gorbach PM, Franco EL, Kahn JA.

J Pediatr Adolesc Gynecol. 2018 Apr;31(2):89-93. doi: 10.1016/j.jpag.2017.09.008. Epub 2017 Sep 21.

Supplemental Content

Loading ...
Support Center